Tumour heterogeneity mainly depends on the presence of several different parameters, which can differ from patient to patients, namely hormone receptors expression, HER2 expression or degree of tumour differentiation but also in areas of the same tumour, also during its progression. Here, NR4A1 is linked to neoplasm.